# Erythroblasts Promote the Development of a Suppressive Lymphocyte Phenotype via Treg Induction and PD1 Upregulation on the Surfaces of B-Cells: A Study on the Subpopulation-Specific Features of Erythroblasts

**Authors:** Kirill Nazarov, Roman Perik-Zavodskii, Julia Shevchenko, Sergey Sennikov

PMC · DOI: 10.3390/cimb47070550 · 2025-07-15

## TL;DR

Erythroblasts influence immune cells by promoting regulatory T cells and increasing PD-1 on B cells, with effects depending on their subpopulation.

## Contribution

The study reveals subpopulation-specific immunoregulatory roles of erythroblasts through Treg induction and PD-1 upregulation.

## Key findings

- Erythroblast-conditioned media promotes Treg development and increases PD-1 on B cells.
- CD45+ erythroblasts upregulate PDL1 and Galectin-9 under hemolytic stress.
- CD45- erythroblasts primarily increase TGFb production.

## Abstract

This study identifies the novel effects of soluble factors derived from murine erythroblasts on lymphoid cell phenotypes. These effects were observed following the treatment of splenic mononuclear cells with erythroblast-conditioned media received from both healthy mice and mice subjected to hematopoiesis-activating conditions (hypoxia, blood loss, and hemolytic anemia), suggesting a common mechanism of action. Using flow cytometry, we elucidated that erythroblast-derived soluble products modulate T cell differentiation by promoting Treg development and increasing PD-1 surface expression on B cells. The immunoregulatory potential of erythroblasts is subpopulation-dependent: CD45+ erythroblasts respond to hemolytic stress by upregulating the surface expression of immunosuppressive molecules PDL1 and Galectin-9, while CD45- erythroblasts primarily increase TGFb production. These findings highlight the regulatory role of erythroblasts in modulating immune responses.

## Linked entities

- **Proteins:** CD274 (CD274 molecule), Lgals9 (lectin, galactose binding, soluble 9), TGFB1 (transforming growth factor beta 1), PDCD1 (programmed cell death 1)
- **Diseases:** hemolytic anemia (MONDO:0003664)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Lgals9 (lectin, galactose binding, soluble 9) [NCBI Gene 16859] {aka LGALS35, Lgals5, gal-9, galectin-9}, Pdcd1 (programmed cell death 1) [NCBI Gene 18566] {aka Ly101, PD-1, Pdc1}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}
- **Diseases:** blood loss (MESH:D016063), hemolytic anemia (MESH:D000743), hypoxia (MESH:D000860)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293808/full.md

---
Source: https://tomesphere.com/paper/PMC12293808